Actively Recruiting

Phase 3
Age: 18Years - 80Years
All Genders
NCT04661358

Fenofibrate for Prevention of DR Worsening

Led by Jaeb Center for Health Research · Updated on 2025-11-13

560

Participants Needed

66

Research Sites

456 weeks

Total Duration

On this page

Sponsors

J

Jaeb Center for Health Research

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with mild to moderately severe non-proliferative DR (NPDR) and no CI-DME at baseline. In addition to evaluating efficacy, this study aims to evaluate the feasibility of a model for ophthalmologists to prescribe or collaborate with a primary care provider such as an internist/endocrinologist to prescribe and monitor the drug safely. If this study demonstrates that fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community of retina specialists, a new strategy to prevent vision threatening complications of diabetes could be widely adopted. Widespread use of an oral agent effective at reducing worsening of DR would decrease the numbers of patients who undergo more invasive and much more expensive treatment for DR and who are consequently at risk for side effects that adversely affect visual function. This study will also assess the relationship of glycemic variability, as measured by continuous glucose monitoring with DR outcomes. Ancillary studies will characterize functional and structural outcomes in this cohort.

CONDITIONS

Official Title

Fenofibrate for Prevention of DR Worsening

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years and under 80 years
  • Diagnosis of type 1 or type 2 diabetes
  • At least one eye with mild to moderately severe non-proliferative diabetic retinopathy (ETDRS level 35 to 47) confirmed by central Reading Center grading
  • Best-corrected visual acuity letter score of 74 or higher (approximate Snellen equivalent 20/32 or better) in the eligible eye
  • If only one eye is eligible, the other eye must have diabetic retinopathy severity level 20 (microaneurysms only)
Not Eligible

You will not qualify if you...

  • Presence of center-involved diabetic macular edema (CI-DME) based on clinical exam or OCT central subfield thickness above specified thresholds
  • Prior treatment for diabetic macular edema or diabetic retinopathy except focal/grid laser more than 12 months ago
  • History of intraocular anti-VEGF or corticosteroid treatment within the past year
  • Decreased kidney function requiring dialysis or eGFR less than 45 mL/min/1.73 m2

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 66 locations

1

Kent W. Small, MD, AMC

Glendale, California, United States, 91203-1971

Actively Recruiting

2

Salehi Retina Institute Inc.

Huntington Beach, California, United States, 92647-8693

Actively Recruiting

3

Loma Linda University

Loma Linda, California, United States, 92354

Actively Recruiting

4

UCLA Stein Eye Institute

Pasadena, California, United States, 91103

Actively Recruiting

5

Regents of the University of California, Davis, DBA University of California, Davis

Sacramento, California, United States, 95817

Actively Recruiting

6

The Regents of the University of California, San Francisco

San Francisco, California, United States, 94110

Actively Recruiting

7

National Ophthalmic Research Institute

Fort Myers, Florida, United States, 33912

Actively Recruiting

8

University of Florida- Jacksonville

Jacksonville, Florida, United States, 32209

Actively Recruiting

9

Florida Retina Institute, James A. Staman, MD, PA- Jacksonville

Jacksonville, Florida, United States, 32216

Actively Recruiting

10

Florida Retina Consultants

Lakeland, Florida, United States, 33805

Actively Recruiting

11

Florida Retina Institute, James A. Staman, MD, PA- Orlando

Orlando, Florida, United States, 32806-1101

Actively Recruiting

12

Southeast Eye Institute, P.A. dba Eye Associates of Pinellas

Pinellas Park, Florida, United States, 33782

Actively Recruiting

13

Retina Vitreous Consultants, LLP

Sarasota, Florida, United States, 34233-1261

Actively Recruiting

14

Sarasota Retina Institute

Sarasota, Florida, United States, 34239

Actively Recruiting

15

SEASHORE RETINA LLC DBA Retina Specialists of Tampa

Wesley Chapel, Florida, United States, 33544

Actively Recruiting

16

Southeast Retina Center, P.C.

Augusta, Georgia, United States, 30909

Actively Recruiting

17

Marietta Eye Clinic

Marietta, Georgia, United States, 30060

Actively Recruiting

18

Thomas Eye Group

Sandy Springs, Georgia, United States, 30328

Actively Recruiting

19

Northwestern University

Chicago, Illinois, United States, 60611

Actively Recruiting

20

Rush University Medical Center

Chicago, Illinois, United States, 60612

Actively Recruiting

21

UIC - Dept of Ophthalmology & Visual Sciences

Chicago, Illinois, United States, 60612

Actively Recruiting

22

Illinois Retina Associates SC - Oak Park Site

Oak Park, Illinois, United States, 60304

Actively Recruiting

23

Midwest Eye Institute

Indianapolis, Indiana, United States, 46290

Actively Recruiting

24

John Kenyon American Eye Institute, LLC

New Albany, Indiana, United States, 47150

Actively Recruiting

25

Wolfe Eye Clinic-Cedar Rapids

Hiawatha, Iowa, United States, 52233

Actively Recruiting

26

Wolfe Clinic, P.C.- West Des Moines

West Des Moines, Iowa, United States, 50266-7705

Actively Recruiting

27

Mid-America Retina Consultants, P.A.

Overland Park, Kansas, United States, 66211

Actively Recruiting

28

University of Kansas Medical Center Research Institute, Inc.

Prairie Village, Kansas, United States, 66208

Actively Recruiting

29

Joseph E. Humble and Raymond Haik PTRS DBA Eye Assoc of Northeast Louisiana

West Monroe, Louisiana, United States, 71291-4452

Actively Recruiting

30

Elman Retina Group, P.A.

Baltimore, Maryland, United States, 21237

Actively Recruiting

31

Valley Eye Physicians and Surgeons

Ayer, Massachusetts, United States, 01432

Actively Recruiting

32

Boston Medical Center Corporation

Boston, Massachusetts, United States, 02118

Actively Recruiting

33

Joslin Diabetes Center

Boston, Massachusetts, United States, 02215

Actively Recruiting

34

Henry Ford Health System

Detroit, Michigan, United States, 48202-2689

Actively Recruiting

35

Foundation for Vision Research and Retina Specialists of Michigan, P.C.

Grand Rapids, Michigan, United States, 49546

Actively Recruiting

36

Vitreo-Retinal Associates

Grand Rapids, Michigan, United States, 49546

Actively Recruiting

37

Retina Center, PA DBA Retina Center of Minnesota

Minneapolis, Minnesota, United States, 55404

Actively Recruiting

38

Mayo Clinic

Rochester, Minnesota, United States, 55905

Actively Recruiting

39

The Curators of the University of Missouri

Columbia, Missouri, United States, 65201-5276

Actively Recruiting

40

Washington University Ophthalmology

St Louis, Missouri, United States, 63110

Actively Recruiting

41

Retina Research Institute, LLC

St Louis, Missouri, United States, 63128-1729

Actively Recruiting

42

Retina-Vitreous Surgeons of Central NY, PC

Liverpool, New York, United States, 13088

Actively Recruiting

43

MaculaCare

New York, New York, United States, 10021

Actively Recruiting

44

Retina Associates of Western NY, P.C.

Rochester, New York, United States, 14620-4655

Actively Recruiting

45

Pamela Weber, MD/Island Retina

Shirley, New York, United States, 11967

Actively Recruiting

46

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States, 27517

Actively Recruiting

47

The Cleveland Clinic Foundation DBA Cleveland Clinic Lerner College of Medicine

Cleveland, Ohio, United States, 44120

Actively Recruiting

48

Dean A. McGee Eye Institute

Oklahoma City, Oklahoma, United States, 73104

Actively Recruiting

49

Verum Research LLC

Eugene, Oregon, United States, 97401

Actively Recruiting

50

Oregon Health & Science University

Portland, Oregon, United States, 97239

Actively Recruiting

51

Retina Consultants, LLC

Salem, Oregon, United States, 97302

Actively Recruiting

52

Cascade Medical Research Institute, LLC

Springfield, Oregon, United States, 97477

Actively Recruiting

53

Retina-Vitreous Consultants, Inc.

Monroeville, Pennsylvania, United States, 15146

Actively Recruiting

54

Pittsburg Clinical Trial Consortium

Sewickley, Pennsylvania, United States, 15143

Actively Recruiting

55

Southeastern Retina Associates, P.C.

Knoxville, Tennessee, United States, 37922

Actively Recruiting

56

Vanderbilt Eye Institute

Nashville, Tennessee, United States, 37232

Actively Recruiting

57

Austin Research Center for Retina

Austin, Texas, United States, 78705

Actively Recruiting

58

Austin Retina Associates

Austin, Texas, United States, 78705

Actively Recruiting

59

Retina Consultants of Texas

Beaumont, Texas, United States, 77707

Actively Recruiting

60

Retina Consultants of Texas, PA

Bellaire, Texas, United States, 77401

Actively Recruiting

61

Baylor College of Medicine, Baylor Eye Physicians and Surgeons

Houston, Texas, United States, 77030-4101

Actively Recruiting

62

Texas Retina Associates

Lubbock, Texas, United States, 79424

Actively Recruiting

63

Retinal Consultants of San Antonio

San Antonio, Texas, United States, 78240

Actively Recruiting

64

University of Washington

Seattle, Washington, United States, 98104

Actively Recruiting

65

Gunderson Health System

La Crosse, Wisconsin, United States, 54601

Actively Recruiting

66

Eye Clinic of Wisconsin

Wausau, Wisconsin, United States, 54403

Actively Recruiting

Loading map...

Research Team

A

Adam R Glassman, MS

CONTACT

E

Emily Chew, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Fenofibrate for Prevention of DR Worsening | DecenTrialz